BREAKING NEWS: $MTP Midatech Pharma PLC Announces Headline Results of MTX110 Phase I DIPG Study
Headline Results of MTX110 Phase I DIPG Study Phase II Dose Confirmed and Encouraging Survival Data ABINGDON, OXFORDSHIRE / ACCESSWIRE / October 19, 2020 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), an R&D biotechnology company focused on improving the bio-delivery and biodist...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.